BIRC6 and hepatocellular carcinoma: Our studies have shown BRUCE is a suppressor of liver genomic instability, fibrosis, and HCC through DNA repair promotion, with clinical relevance demonstrated by its downregulation in 84% of HCC and 50% of MASLD/MASH cases [18, 19].